Faisal Shaukat Ali, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis | 8 | 2020 | 1231 | 0.710 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1182 | 0.390 |
Why?
|
| Gastrointestinal Agents | 2 | 2019 | 508 | 0.230 |
Why?
|
| Cognition Disorders | 1 | 2018 | 3975 | 0.220 |
Why?
|
| Diarrhea | 2 | 2020 | 1317 | 0.200 |
Why?
|
| Duodenal Diseases | 1 | 2022 | 99 | 0.200 |
Why?
|
| Duodenal Neoplasms | 1 | 2022 | 115 | 0.190 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 506 | 0.180 |
Why?
|
| Enterocolitis, Neutropenic | 1 | 2020 | 2 | 0.180 |
Why?
|
| Intestinal Perforation | 2 | 2019 | 249 | 0.180 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 8981 | 0.170 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2020 | 82 | 0.170 |
Why?
|
| Radioimmunotherapy | 1 | 2019 | 91 | 0.170 |
Why?
|
| Histoplasmosis | 1 | 2019 | 63 | 0.160 |
Why?
|
| Urine | 1 | 2020 | 363 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 124 | 0.160 |
Why?
|
| Digestive System Neoplasms | 1 | 2018 | 81 | 0.160 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2019 | 79 | 0.150 |
Why?
|
| Intussusception | 1 | 2019 | 115 | 0.150 |
Why?
|
| Bile Duct Neoplasms | 1 | 2023 | 602 | 0.150 |
Why?
|
| Drainage | 1 | 2023 | 1161 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 277 | 0.140 |
Why?
|
| Jejunum | 1 | 2019 | 471 | 0.140 |
Why?
|
| Pleural Effusion | 1 | 2020 | 342 | 0.140 |
Why?
|
| Neoplasms | 7 | 2020 | 22030 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 341 | 0.130 |
Why?
|
| Endoscopy, Digestive System | 1 | 2018 | 351 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 433 | 0.120 |
Why?
|
| Necrosis | 1 | 2019 | 1604 | 0.120 |
Why?
|
| Arthralgia | 1 | 2019 | 461 | 0.120 |
Why?
|
| Colonoscopy | 2 | 2019 | 1388 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 856 | 0.110 |
Why?
|
| Neutropenia | 1 | 2018 | 884 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2019 | 1207 | 0.110 |
Why?
|
| Brain | 1 | 2019 | 26951 | 0.100 |
Why?
|
| Laser Therapy | 1 | 2019 | 1089 | 0.100 |
Why?
|
| Dyspnea | 1 | 2020 | 1344 | 0.100 |
Why?
|
| Immunosuppressive Agents | 3 | 2020 | 4158 | 0.100 |
Why?
|
| Clostridium Infections | 1 | 2019 | 557 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12951 | 0.100 |
Why?
|
| Stents | 1 | 2023 | 3162 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 9160 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2148 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 1110 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1185 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1172 | 0.090 |
Why?
|
| Melanoma | 2 | 2019 | 5691 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2197 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 1454 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1585 | 0.080 |
Why?
|
| Colostomy | 2 | 2019 | 105 | 0.080 |
Why?
|
| Endoscopy | 1 | 2018 | 1834 | 0.080 |
Why?
|
| Texas | 2 | 2020 | 402 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1890 | 0.070 |
Why?
|
| Incidence | 3 | 2020 | 21273 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2023 | 80170 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2019 | 2001 | 0.070 |
Why?
|
| Plastics | 1 | 2023 | 115 | 0.050 |
Why?
|
| Humans | 21 | 2023 | 758381 | 0.050 |
Why?
|
| Intestinal Polyps | 1 | 2022 | 104 | 0.050 |
Why?
|
| Middle Aged | 13 | 2023 | 219560 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15785 | 0.050 |
Why?
|
| Survival Rate | 3 | 2020 | 12721 | 0.050 |
Why?
|
| Male | 15 | 2023 | 358742 | 0.040 |
Why?
|
| Aged | 10 | 2023 | 168217 | 0.040 |
Why?
|
| Thioguanine | 1 | 2019 | 44 | 0.040 |
Why?
|
| Comorbidity | 3 | 2019 | 10495 | 0.040 |
Why?
|
| Daunorubicin | 1 | 2019 | 156 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6852 | 0.040 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2023 | 550 | 0.040 |
Why?
|
| Asparaginase | 1 | 2019 | 240 | 0.040 |
Why?
|
| Female | 13 | 2023 | 390316 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2019 | 238 | 0.040 |
Why?
|
| Gastritis | 1 | 2019 | 199 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 251 | 0.040 |
Why?
|
| Cytarabine | 1 | 2019 | 696 | 0.040 |
Why?
|
| Biopsy | 2 | 2018 | 6768 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 600 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15638 | 0.030 |
Why?
|
| Palliative Care | 2 | 2023 | 3570 | 0.030 |
Why?
|
| Debridement | 1 | 2019 | 492 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2022 | 64379 | 0.030 |
Why?
|
| Cough | 1 | 2020 | 594 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 73806 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 983 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1097 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 662 | 0.030 |
Why?
|
| Prognosis | 3 | 2020 | 29558 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2283 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 1630 | 0.030 |
Why?
|
| Adult | 5 | 2020 | 219916 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 11152 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2882 | 0.030 |
Why?
|
| Colectomy | 1 | 2019 | 692 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2020 | 867 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 1198 | 0.030 |
Why?
|
| Age Factors | 2 | 2020 | 18357 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 1617 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36285 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1056 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6233 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 1526 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2144 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6293 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2751 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6493 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2500 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 23883 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41252 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2018 | 9650 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11070 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12096 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10505 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12440 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9273 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5248 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7377 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11709 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 58681 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 39873 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13591 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 58808 | 0.010 |
Why?
|
| United States | 1 | 2018 | 72140 | 0.010 |
Why?
|